Jefferies Financial Group Issues Pessimistic Forecast for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price target decreased by equities research analysts at Jefferies Financial Group from $356.00 to $349.00 in a research note issued on Thursday,MarketScreener reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. Jefferies Financial Group’s price target suggests a potential upside of 15.46% from the stock’s previous close.

Other equities analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft lifted their price target on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a report on Thursday, February 5th. UBS Group reissued a “neutral” rating and issued a $310.00 target price on shares of CME Group in a report on Friday, February 6th. Argus reissued a “hold” rating on shares of CME Group in a report on Wednesday, March 4th. Finally, Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, March 5th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $307.88.

CME Group Stock Down 0.2%

Shares of CME Group stock opened at $302.26 on Thursday. The business has a 50-day moving average of $306.06 and a 200-day moving average of $284.06. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.03. The company has a market capitalization of $108.40 billion, a PE ratio of 27.07, a P/E/G ratio of 3.25 and a beta of 0.26. CME Group has a 1-year low of $251.90 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company’s revenue was up 8.1% on a year-over-year basis. During the same period last year, the firm earned $2.52 earnings per share. As a group, equities analysts forecast that CME Group will post 10.49 EPS for the current fiscal year.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director owned 43,007 shares in the company, valued at $13,317,117.55. This represents a 8.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 8,539 shares of company stock worth $2,713,821 over the last ninety days. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. West Family Investments Inc. grew its position in CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after buying an additional 37 shares during the last quarter. Asset Dedication LLC grew its position in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC grew its position in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after buying an additional 37 shares during the last quarter. Rehmann Capital Advisory Group grew its position in CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares during the last quarter. Finally, Atlatl Advisers LLC grew its position in CME Group by 1.8% in the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after buying an additional 38 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 volumes — CME reported international average daily volume (ADV) hit a record 11.4M contracts in Q1, up ~30% YoY, with all major product suites posting quarterly international ADV records; stronger ADV typically boosts transaction revenue and supports earnings durability. CME Group International ADV Reaches Record 11.4M Contracts in Q1 2026
• Positive Sentiment: Crypto product expansion — CME is adding Avalanche (AVAX) and Sui (SUI) futures (micro and standard sizes) with a planned May 4 rollout, and is advancing a broader 24/7 crypto offering; these moves expand addressable market and could lift future trading volumes and fees. CME Group to Launch Avalanche and Sui Futures
• Positive Sentiment: Analyst optimism — several broker notes surfaced: an average “Moderate Buy” consensus and a Raymond James note saying the stock is likely to rise, reflecting analyst confidence in CME’s revenue trends and product-led growth. CME Given Average Recommendation of Moderate Buy
• Positive Sentiment: Barclays raised its price target to $344 (from $312) — a material lift to modeled upside even as the firm kept an equal-weight rating, signaling higher long-term valuation assumptions. Barclays Adjusts Price Target on CME Group to $344
• Neutral Sentiment: New coverage and modest PTs — Keefe, Bruyette & Woods started coverage with a “market perform” and $305 target, a cautious near-term view that may limit upside from some investors. Keefe Bruyette & Woods Starts Coverage
• Neutral Sentiment: Macro/market flow context — CME’s market data is being widely cited (e.g., Fed-cut odds), and large block trades in oil and other futures routed through venues CME operates have driven episodic volatility and volume; this boosts ADV but can also cause short-term price swings in the stock. Markets Shift Toward Potential Fed Rate Cut; CME Data Cited
• Neutral Sentiment: Third‑party SPAC crypto financing references CME rates — an Evernorth SEC filing ties XRP pricing/valuation mechanics to CME CF rates, highlighting CME’s role in broader crypto market structure but with indirect and uncertain revenue implication. Evernorth Amended SEC Filing Deepens XRP Role
• Negative Sentiment: Regulatory/approval risk for crypto products — the AVAX and SUI futures launches are pending regulatory approval; any delays or restrictions could push out expected revenue gains and keep investor caution elevated. CME Group Launch Avalanche and Sui Futures

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.